Among the top dividend stocks that I post every month, many of the top payers are pharmaceutical companies that are in the business of doing research, inventing and then marketing drugs that will solve all types of problems. These companies typically have strong balance sheets and certainly look like very attractive dividend stocks. We decided to take a deeper look into these stocks to see if they were worth holding in a diversified dividend portfolio.
In my opinion, the conclusion is not to avoid pharma companies but rather to avoid a high concentration of pharma stocks in a dividend portfolio. Those stocks, like financials, carry their load of risk right now. They are good dividend payers and might remain so in the future. But be careful and do not include most of your stocks in this portfolio.
Source: Intelligent Speculator
Related Articles:
Dividend Growth Stocks News
- The Smartest Dividend Stocks to Buy With $350 Right Now - Yahoo Finance - 7/26/2025
- The Smartest Real Estate Dividend Stocks to Buy With $2,000 Right Now - The Motley Fool - 7/26/2025
- Top 5 Dividend Stocks Outperform Market Turmoil With Gains Up to 81.8% in 2025 - 24/7 Wall St. - 7/26/2025
- The 3 Buffett-Backed Dividend Stocks That Beat The Market In 2025 - Barchart.com - 7/25/2025
- The 3 Most Defensible Dividend Stocks for $350 in Uncertain Times - AInvest - 7/26/2025
- Duke Energy (DUK) Dividend Stock Analysis - 7/25/2025
- Chevron Corporation (CVX) Dividend Stock Analysis - 7/18/2025
- Emerson Electric Co. (EMR) Dividend Stock Analysis - 7/11/2025
- Amgen, Inc. (AMGN) Dividend Stock Analysis - 6/27/2025
- W.W. Grainger, Inc. (GWW) Dividend Stock Analysis - 6/20/2025
You should worry about Big Pharma's dividends
Posted by D4L | Tuesday, December 21, 2010 | ArticleLinks | 0 comments »________________________________________________________________
Subscribe to:
Post Comments (Atom)
0 comments
Post a Comment
Post a Comment
Note: Only a member of this blog may post a comment.